Novartis AGNVSNYSE
Loading
Earnings before interest, taxes, depreciation, and amortization
3Y CAGR
+16.1%/yr
vs -7.7%/yr prior
5Y CAGR
+6.0%/yr
Recent acceleration
Acceleration
+23.8pp
Accelerating
Percentile
P93
Near historical high
vs 5Y Ago
1.3x
Solid growth
Streak
3 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $22.99B | +11.0% |
| 2024 | $20.71B | +13.5% |
| 2023 | $18.25B | +24.3% |
| 2022 | $14.68B | -52.5% |
| 2021 | $30.91B | +79.6% |
| 2020 | $17.21B | +10.2% |
| 2019 | $15.62B | -22.8% |
| 2018 | $20.24B | +38.7% |
| 2017 | $14.59B | +0.1% |
| 2016 | $14.57B | - |